Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

Multiple myeloma (MM) is the third most common hematologic malignancy in Korea. Historically, the incidence of MM in Korea has been lower than that in Western populations, although there is growing evidence that the incidence of MM in Asian populations, including Korea, is increasing rapidly. Despit...

Full description

Bibliographic Details
Main Authors: Kim, Hyo Jung, Yoon, Sung-Soo, Eom, Hyeon Seok, Kim, Kihyun, Kim, Jin Seok, Lee, Je-Jung, Bang, Soo-Mee, Min, Chang-Ki, Park, Joon Seong, Lee, Jae-Hoon
Format: Online
Language:English
Published: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377347/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377347/

Similar Items